When it comes to science, deep technology, and the advancement of human civilization — China has ambitions not just to compete, but to lead. Don’t miss a beat in China’s steady progress in all things science, health, medicine, and deep technology.
“We’re at a point now where technology and policy are reinforcing each other, so we have a lot more reason to be optimistic about green finance and climate probably than any other time in the past fifteen or twenty years,” says Damien Ma, Director of the Paulson Institute’s think tank.
On the same day that U.S. regulators cleared the way for the Johnson & Johnson vaccine to become the country's third approved COVID-19 shot, two more Chinese companies applied for public rollouts of their vaccines in China.
WHO scientists had arguments in Wuhan over access to detailed patient data. But they appear to disagree about whether those debates amount to a “refusal” by China to share information essential to tracing the origin of COVID-19.
China is millions of doses behind the U.S. in its COVID-19 vaccine rollout, and officials are reportedly pushing back their timeline for the first 50 million shots. Vaccine diplomacy abroad, and vaccine hesitancy at home, are slowing China’s domestic rollout.
CoronaVac, a vaccine by Sinovac Biotech, may only be a little more than 50% effective in preventing COVID-19, according to clinical trial results in Brazil. While this clears the threshold for regulatory approval, it is a disappointing result for countries that already bought tens of millions of doses of the product.
The province surrounding Beijing is responding rapidly to a new outbreak of COVID-19, hoping to stop the spread of the virus before travel for Chinese New Year commences.
Chinese regulators gave approval for a mass public rollout of a COVID-19 vaccine by Sinopharm on December 30, 2020. Meanwhile, authorities worked to expand an emergency use authorization program that has already delivered millions of experimental vaccine doses.
The Chang’e-5 probe has landed in Inner Mongolia with a cargo of lunar rocks and soil.
Countries including Indonesia, Brazil, Turkey, and Chile are clamoring for doses of CoronaVac, the vaccine candidate made by Sinovac Biotech. Meanwhile, the maker of another of China’s leading vaccine candidates, Sinopharm, applied last month for market approval.